Table 2 Patient characteristics
From: The immune cell landscape of metastatic uveal melanoma correlates with overall survival
| Â | N | % |
|---|---|---|
Gender | ||
 Female | 9 | 42.9 |
 Male | 12 | 57.1 |
Age at diagnosis of primary UM, years | ||
 Median (IQR) | 61 (49–66) |  |
Age at diagnosis of UM metastasis, years | ||
 Median (IQR) | 65 (57–70) |  |
Metastasis site | ||
 Liver | 17 | 81.0 |
 Extra-hepatic | 4 | 19.0 |
Liver involvement (n = 17), % | ||
 < 20 | 8 | 47.1 |
 20–50 | 8 | 47.1 |
 > 50 | 1 | 5.8 |
LDH | ||
 Normal | 15 | 71.4 |
 > 1ULN | 6 | 28.6 |
Treatment | ||
 Checkpoint inhibitors immunotherapy | 13 | 61.9 |
 Targeted/Systemic therapies | 8 | 38.1 |
Response | ||
 PD | 7 | 33.3 |
 SD | 7 | 33.3 |
 PR | 6 | 28.6 |
 CR | 1 | 4.8 |
Status | ||
 Alive with disease | 11 | 52.4 |
 Dead | 10 | 47.6 |